Morrison, M. M., Williams, M. M., Vaught, D. B., Hicks, D., Lim, J., McKernan, C., . . . Cook, R. S. (2015). Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth. Oncogene.
Παραπομπή Chicago StyleMorrison, Meghan M., et al. "Decreased LRIG1 in Fulvestrant-treated Luminal Breast Cancer Cells Permits ErbB3 Upregulation and Increased Growth." Oncogene 2015.
Παραπομπή MLAMorrison, Meghan M., et al. "Decreased LRIG1 in Fulvestrant-treated Luminal Breast Cancer Cells Permits ErbB3 Upregulation and Increased Growth." Oncogene 2015.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.